.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Fish and Richardson
Daiichi Sankyo
Medtronic
Fuji
Baxter
US Army
Johnson and Johnson
Teva
Citi

Generated: December 17, 2017

DrugPatentWatch Database Preview

Nalidixic acid - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for nalidixic acid and what is the scope of nalidixic acid patent protection?

Nalidixic acid
is the generic ingredient in two branded drugs marketed by Sanofi Aventis Us, Sun Pharm Industries, and Watson Labs, and is included in eight NDAs. Additional information is available in the individual branded drug profile pages.

There are two drug master file entries for nalidixic acid.

Medical Subject Heading (MeSH) Categories for nalidixic acid

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sanofi Aventis UsNEGGRAMnalidixic acidTABLET;ORAL014214-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Watson LabsNALIDIXIC ACIDnalidixic acidTABLET;ORAL071936-001Jun 29, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe
Watson LabsNALIDIXIC ACIDnalidixic acidTABLET;ORAL072061-001Jun 29, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe
Watson LabsNALIDIXIC ACIDnalidixic acidTABLET;ORAL071919-001Jun 29, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe
Sun Pharm IndustriesNALIDIXIC ACIDnalidixic acidTABLET;ORAL070272-001Jun 29, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe
Sun Pharm IndustriesNALIDIXIC ACIDnalidixic acidTABLET;ORAL070271-001Jun 29, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe
Sanofi Aventis UsNEGGRAMnalidixic acidTABLET;ORAL014214-004Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Sanofi Aventis UsNEGGRAMnalidixic acidSUSPENSION;ORAL017430-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Sun Pharm IndustriesNALIDIXIC ACIDnalidixic acidTABLET;ORAL070270-001Jun 29, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe
Sanofi Aventis UsNEGGRAMnalidixic acidTABLET;ORAL014214-005Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: nalidixic acid

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Sanofi Aventis UsNEGGRAMnalidixic acidSUSPENSION;ORAL017430-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Sanofi Aventis UsNEGGRAMnalidixic acidTABLET;ORAL014214-002Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Sanofi Aventis UsNEGGRAMnalidixic acidTABLET;ORAL014214-004Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Sanofi Aventis UsNEGGRAMnalidixic acidTABLET;ORAL014214-005Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Sanofi Aventis UsNEGGRAMnalidixic acidSUSPENSION;ORAL017430-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Boehringer Ingelheim
Fuji
UBS
US Department of Justice
Moodys
Merck
Baxter
Cantor Fitzgerald
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot